Filing Details
- Accession Number:
- 0001088020-11-000022
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-03-03 16:40:37
- Reporting Period:
- 2011-03-01
- Filing Date:
- 2011-03-03
- Accepted Time:
- 2011-03-03 16:40:37
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
911216 | Palatin Technologies Inc | PTN | Pharmaceutical Preparations (2834) | 954078884 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1042011 | Carl Spana | Palatin Technologies, Inc. 4C Cedar Brook Drive Cranbury NJ 08512 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2011-03-01 | 50,000 | $0.00 | 104,806 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series A common stock purchase warrant | Acquisiton | 2011-03-01 | 4,348 | $0.00 | 4,348 | $1.00 |
Common Stock | Series B common stock purchase warrant | Acquisiton | 2011-03-01 | 45,652 | $0.00 | 45,652 | $1.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
4,348 | 2011-03-01 | 2016-03-01 | No | 4 | P | Direct |
45,652 | 2012-03-02 | 2017-03-02 | No | 4 | P | Direct |
Footnotes
- Included in the purchase of 50,000 Units at a price of $1.00 per Unit. Each Unit consisted of one share of common stock; a Series A Warrant exercisable immediately for 2/23 of a share of common stock at an exercise price of $1.00 per share, with an expiration date of March 1, 2016; and a Series B Warrant exercisable starting March 2, 2012 for 21/23 of a share of common stock at an exercise price of $1.00 per share, with an expiration date of March 2, 2017. Exercise of the Series B warrant is subject to stockholder approval of an increase in the issuer's authorized capital.